| - GRCh37:
- Chr3:52485301
- GRCh38:
- Chr3:52451285
| TNNC1 | G159D | not provided | Likely pathogenic (Jan 13, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52485407
- GRCh38:
- Chr3:52451391
| TNNC1 | E152K | Dilated cardiomyopathy 1Z | Pathogenic (Apr 30, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr3:52485759
- GRCh38:
- Chr3:52451743
| TNNC1 | | not provided | Pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr3:52485787
- GRCh38:
- Chr3:52451771
| TNNC1 | L97Q | not provided | Likely pathogenic (Apr 8, 2013) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52486156
- GRCh38:
- Chr3:52452140
| TNNC1 | E56D | Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13 | Likely pathogenic (Sep 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52486163
- GRCh38:
- Chr3:52452147
| TNNC1 | P54H | not provided | Likely pathogenic (Jan 9, 2013) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52486183
- GRCh38:
- Chr3:52452167
| TNNC1 | M47I | not provided | Likely pathogenic (May 13, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr3:52486233
- GRCh38:
- Chr3:52452217
| TNNC1 | A31S | Hypertrophic cardiomyopathy 13 | Pathogenic (Sep 14, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr3:52488009
- GRCh38:
- Chr3:52453993
| TNNC1 | A8V | Cardiovascular phenotype, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, Hypertrophic cardiomyopathy 13, Dilated cardiomyopathy 1Z, not provided, Cardiomyopathy, Hypertrophic cardiomyopathy | Pathogenic/Likely pathogenic (Feb 23, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr3:52488024
- GRCh38:
- Chr3:52454008
| TNNC1 | D3V | not provided | Likely pathogenic (May 2, 2014) | criteria provided, single submitter |